Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Diekman
AddedMar 31, 2024
UpdatedMay 31, 2026
John Diekman

John Diekman

Board Member, Zai Lab

Crunchbase

John Diekman's Career

Zai Lab
Zai Lab

Shanghai, Shanghai, CN

Board Member· Board
5AM Ventures
5AM Ventures

Menlo Park, CA, US

Co-Founder
Bay City Capital
Bay City Capital

San Francisco, CA, US

Co-Founder
Igenica
Igenica

Burlingame, CA, US

Board Member· Board
Wildcat Discovery Technologies
Wildcat Discovery Technologies

San Diego, CA, US

Board Member· Board
Phenomix
Phenomix

San Diego, CA, US

Board Member· Board
Scripps Research Institute
Scripps Research Institute

Los Angeles, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Diekman's Career

Zai Lab
Zai Lab
Public$1.7B2k2014Shanghai, Shanghai, CN
Board Member· Board

Leadership at Zai Lab

Scott MorrisonScott MorrisonBoard Member
Peter WirthPeter WirthBoard Member
Samantha DuSamantha DuBoard Member
Nisa LeungNisa LeungBoard Member
5AM Ventures
5AM Ventures
Investment FirmInvestment Firm492002Menlo Park, CA, US
Co-Founder

Leadership at 5AM Ventures

Andy SchwabAndy SchwabCo-Founder

Similar to 5AM Ventures

Versant VenturesVersant VenturesSan Francisco, CA, USest. 1999Versant VenturesSan Francisco, CA, US · est. 1999

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Investment Firm68
Atlas VentureAtlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29
Vida VenturesVida VenturesBoston, MA, USest. 2019Vida VenturesBoston, MA, US · est. 2019

Vida Ventures Advisors LLC: A bicoastal venture capital firm investing in life sciences, healthcare, and biotech.

Investment Firm29
Amkey VenturesAmkey VenturesFremont, CA, USest. 2001Amkey VenturesFremont, CA, US · est. 2001

Amkey Ventures, LLC: A US-based venture capital firm specializing in seed and start-up biotech investments.

Investment Firm6
Bay City Capital
Bay City Capital
Investment FirmInvestment Firm251997San Francisco, CA, US
Co-Founder

Leadership at Bay City Capital

FREDERICK BERNARD CRAVESFREDERICK BERNARD CRAVESCo-Founder
Igenica
Igenica
Pre-Seed$80.6M112008Burlingame, CA, US
Board Member· Board

Leadership at Igenica

Mark A. GoldsmithMark A. GoldsmithBoard Member
Robert SchreiberRobert SchreiberBoard Member
David GoeddelDavid GoeddelBoard Member
Carl L. GordonCarl L. GordonBoard Member
Wildcat Discovery Technologies
Wildcat Discovery Technologies
Series D$160M1162006San Diego, CA, US
Board Member· Board

Leadership at Wildcat Discovery Technologies

Tom BaruchTom BaruchBoard Member
Troy WilsonTroy WilsonFounder
Mike WillisMike WillisBoard Member
C. Robert KidderC. Robert KidderBoard Member
Mark GresserMark GresserCEO
Phenomix
Phenomix
Public$106.6M62001San Diego, CA, US
Board Member· Board

Leadership at Phenomix

Damion WickerDamion WickerBoard Member
Pete SchultzPete SchultzFounder
James A HarperJames A HarperBoard Member

Similar to Phenomix

Phenomix SciencesPhenomix SciencesRochester, MN, USBiotechest. 2017Phenomix SciencesRochester, MN, US · est. 2017

Phenomix Sciences: A biotech firm excelling in life science, metabolomics, and genomics.

Pre-Seed · $3.2M5
PhylosPhylosLexington, KY, USBiopharmaceuticalsPhylosLexington, KY, US

Phylos: A crop science firm committed to discovering and developing innovative biopharmaceuticals.

Series B · $25M6
Phenomics HealthPhenomics HealthPlymouth, MI, USBioinformatics, Precision Medicineest. 2018Phenomics HealthPlymouth, MI, US · est. 2018

Phenomics Health: A precision medicine firm leveraging bioinformatics platforms.

Series A · $11.5M36
Denovo BiopharmaDenovo BiopharmaSan Diego, CA, USBiotechnology, Drug Developmentest. 2011Denovo BiopharmaSan Diego, CA, US · est. 2011

Denovo Biopharma, LLC: A private US biotech firm specializing in personalized drug development solutions.

Series D · $1.2B36
Scripps Research Institute
Scripps Research Institute
Series D$370.8M1k1993Los Angeles, CA, US
Board Member· Board

Leadership at Scripps Research Institute

Donna BlackmondDonna BlackmondBoard Member
Ellen Browning ScrippsEllen Browning ScrippsFounder
Kirill MartemyanovKirill MartemyanovBoard Member
Patrick GriffinPatrick GriffinBoard Member
Matthew D. DisneyMatthew D. DisneyBoard Member

Similar to Scripps Research Institute

Scripps Translational Science InstituteScripps Translational Science InstituteLos Angeles, CA, USGenomic Researchest. 2006Scripps Translational Science InstituteLos Angeles, CA, US · est. 2006

LA-based Scripps Translational Science Institute pioneers genomic advances into diagnostics and treatments, with a focus on lifestyle changes.

Series C · $34M31
Novartis Institutes For Biomedical ResearchNovartis Institutes For Biomedical ResearchCambridge, MA, USDrug Discoveryest. 2002Novartis Institutes For Biomedical ResearchCambridge, MA, US · est. 2002

Novartis Institutes For Biomedical Research: A noncommercial research organization founded in 2002.

10k
UC San DiegoUC San DiegoLos Angeles, CA, USResearchest. 1960UC San DiegoLos Angeles, CA, US · est. 1960

UC San Diego: A leading public research university in La Jolla, California, offering 200+ degree programs.

Pre-Seed · $24.6M16.3k
Institute for Systems BiologyInstitute for Systems BiologySeattle, WA, USBiomedical Researchest. 2000Institute for Systems BiologySeattle, WA, US · est. 2000

ISB: A non-profit institute conducting biomedical research for cures and prevention of diseases and cancers.

Series B · $13M230

John Diekman's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to John Diekman

Kenneth KronerKenneth KronerBoard Member · Alberta Investment ManagementEric TopolEric TopolBoard Member · DexcomCraig C TaylorCraig C TaylorCo-Founder · Alloy VenturesSteve PaulSteve PaulBoard Member · Voyager Therapeutics